(PRWEB) August 09, 2012
Novel Health Strategies, LLC and leading healthcare experts in market access planning and medical product reimbursement are hosting a one-of-a-kind seminar in Copenhagen, Denmark.
This unique one-day seminar brings together industry and government advisors, experts from private health plans and the International Society for Pharmacoeconomics and Outcomes Research, to discuss how manufacturers most efficiently can justify reimbursement to the payers. Presentations and case studies will provide valuable understanding of the following issues:
- Trends and challenges in pharmaceutical and device reimbursement
- The US reimbursement system, components and processes
- Understanding payers and their challenges
- Health care reform impact on reimbursement
- Applied Health Technology Assessment
- Effect of US health care reform on evaluation and pricing of new therapies
- Shaping a pricing and reimbursement strategy supported by clinical data
Additionally, the seminar offers a rare opportunity for one-to-one meetings with the experts. The meetings will take place after the seminar, and must be booked when registering. Considering the amount of meetings, it is expected that the meetings will be limited to 15-20 minutes each.
During the seminar there will be coffee breaks and a one hour lunch buffet. We will end the day with a networking reception with light refreshments and snacks during and after the one-to-one meetings.
Date and Time
September 12th 2012, 9am - 5.30pm
The seminar will take place in Eigtveds Pakhus at the Ministry of Foreign Affairs in Copenhagen.
Full program agenda and registration details are available at http://usa.um.dk/en/the-trade-council/the-trade-council-offers1/seminars/health-care-market-access-seminar/program/
About Novel Health Strategies
Novel Health Strategies, LLC (http://www.novelhealthstrategies.com) is an award winning team of experienced professionals with expertise in healthcare strategy, research, policy, publications, health economics and outcomes research, modeling, and pricing and market access strategy. Novel Health team has led strategy projects for majority of top 50 pharmaceutical, biotech and device companies. Novel Health has large network of internal and external stakeholders and has published several thought leading strategy perspectives, including the 'What's fueling the biotech engine' annual series in Nature Biotech, cited and quoted by more than two hundred peer-reviewed publications and agencies (FDA, EMA and others). Novel Health has presented industry trends and perspectives at ISPOR, AMCP and BIO meetings.